Abstract
The main features of randomized clinical trials performed in the field of hypertension treatment are reviewed, based either on the evaluation of clinical events or on the assessment of surrogate outcome measures. The advantages, limitations, and clinical relevance of each approach are highlighted.
| Original language | English |
|---|---|
| Pages (from-to) | 294-297 |
| Number of pages | 4 |
| Journal | Current Hypertension Reports |
| Volume | 7 |
| Issue number | 4 |
| Publication status | Published - Aug 2005 |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Intermediate versus hard end points in clinical trials on hypertension. / Grassi, Guido.
In: Current Hypertension Reports, Vol. 7, No. 4, 08.2005, p. 294-297.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Intermediate versus hard end points in clinical trials on hypertension
AU - Grassi, Guido
PY - 2005/8
Y1 - 2005/8
N2 - The main features of randomized clinical trials performed in the field of hypertension treatment are reviewed, based either on the evaluation of clinical events or on the assessment of surrogate outcome measures. The advantages, limitations, and clinical relevance of each approach are highlighted.
AB - The main features of randomized clinical trials performed in the field of hypertension treatment are reviewed, based either on the evaluation of clinical events or on the assessment of surrogate outcome measures. The advantages, limitations, and clinical relevance of each approach are highlighted.
UR - http://www.scopus.com/inward/record.url?scp=24944494144&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=24944494144&partnerID=8YFLogxK
M3 - Article
C2 - 16061049
AN - SCOPUS:24944494144
VL - 7
SP - 294
EP - 297
JO - Current Hypertension Reports
JF - Current Hypertension Reports
SN - 1522-6417
IS - 4
ER -